Insider Stock Trading History of Clark David C


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Clark David C since year 2005. The trader's CIK number is 1290061. At the time of this reporting, Clark David C is the VP, Finance of Allos Therapeutics Inc . (stock ticker symbol ALTH). See this page for all insider trading activities at Allos Therapeutics Inc .


Stock purchases, sales, and option exercises reported by insider Clark David C since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2012-02-29 ALTH Allos Therapeutics Inc Sale 3,388 1.52 5,163
2012-03-01 ALTH Allos Therapeutics Inc Sale 3,385 1.50 5,074
2012-02-23 ALTH Allos Therapeutics Inc Sale 1,460 1.57 2,290
2012-02-24 ALTH Allos Therapeutics Inc Sale 595 1.55 922
2011-11-16 ALTH Allos Therapeutics Inc Sale 125 1.43 178
2011-11-15 ALTH Allos Therapeutics Inc Sale 5,438 1.45 7,863
2011-02-23 ALTH Allos Therapeutics Inc Sale 1,365 3.25 4,438
2011-02-24 ALTH Allos Therapeutics Inc Sale 557 3.12 1,739
2010-05-10 ALTH Allos Therapeutics Inc Option Ex 3,085 2.82 8,684
2010-05-10 ALTH Allos Therapeutics Inc Sale 3,085 7.03 21,684
2010-03-10 ALTH Allos Therapeutics Inc Option Ex 20,000 4.78 95,600
2010-03-10 ALTH Allos Therapeutics Inc Sale 20,000 7.78 155,620
2010-03-04 ALTH Allos Therapeutics Inc Option Ex 8,915 2.82 25,095
2010-03-05 ALTH Allos Therapeutics Inc Option Ex 10,000 2.93 29,300
2010-03-04 ALTH Allos Therapeutics Inc Sale 11,640 6.98 81,305
2010-03-05 ALTH Allos Therapeutics Inc Sale 10,000 7.02 70,200
2009-03-13 ALTH Allos Therapeutics Inc Option Ex 5,027 2.93 14,729
2009-03-12 ALTH Allos Therapeutics Inc Option Ex 64,973 2.59 168,410
2009-03-13 ALTH Allos Therapeutics Inc Sale 5,027 7.00 35,189
2009-03-12 ALTH Allos Therapeutics Inc Sale 64,973 7.02 455,785
2005-06-30 ALTH Allos Therapeutics Inc Buy 272 1.85 504

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Clark David C (VP, Finance of Allos Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.